Weekly Recap | Constellation Brands -1.92%, most brokers rate it buy

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Constellation Brands (STZ) fell 1.92% this week, finishing Friday at $128.18 versus the prior Friday’s close of $130.69. The S&P 500 edged up 0.09% over the same period, leaving the stock roughly 2.01 percentage points behind the benchmark. The week started on a firmer footing, with the stock touching an intraday high of $132.89 by Wednesday before sliding below $130. Thursday marked the week’s low at $127.36, and Friday saw a modest recovery into the close.

The Week

Constellation Brands (STZ) fell 1.92% this week, finishing Friday at $128.18 versus the prior Friday’s close of $130.69. The S&P 500 edged up 0.09% over the same period, leaving the stock roughly 2.01 percentage points behind the benchmark. The week started on a firmer footing, with the stock touching an intraday high of $132.89 by Wednesday before sliding below $130. Thursday marked the week’s low at $127.36, and Friday saw a modest recovery into the close. Overall it was a fading move with a weekly range of 4.24%.

Key Events

There were no company-specific announcements for STZ this week. The narrative instead centred on margin defence across the consumer goods space. Reports highlighted a mixed second quarter for mid-cap US equities, with several companies facing cost pressure. The same week brought news of a leadership change at Coca-Cola and British American Tobacco cutting around 9,000 jobs, reinforcing the focus on de-leveraging and cost control among consumer staples. Constellation Brands sits within that broader sentiment, though it released no fresh operating data of its own.

Analyst Ratings

Among 25 firms covering the stock, 11 rate it buy, 3 rate it overweight, 8 rate it hold, 2 rate it underweight, none rate it sell, and 1 has no opinion. The consensus recommendation is buy, with a consensus target of about $170.83, implying roughly 33.27% upside from the current price of $128.18. Target prices range from $115 to $209, reflecting wide dispersion. The stock ranks 1st among 10 peers in its industry, signalling relatively strong coverage interest.

The Week Ahead

STZ has no earnings date on the calendar next week, but the US market will digest several macro releases, including NFIB small business optimism, initial jobless claims, final demand PPI, and existing home sales on an annualised basis. The PPI and jobless claims prints due on 10 September may shape views on cost and consumer resilience. For the alcoholic beverage sector, downstream demand and price pass-through remain worth tracking, though there is no clear company-level catalyst yet.

In Short

This week set up a tension between price action and analyst conviction: the stock faded and lagged the market, while the sell-side view remains constructive, with the consensus target well above spot and a top industry ranking. The latest session’s money flow shows large-lot money on the net sell side, and valuation is not stretched. The next question is whether cost pressures in consumer staples ease and whether views on beverage demand resilience diverge further.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.

Source: Weekly Review The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.